$LLY INSIGHTS →Eli Lilly (LLY) agreed to acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion.
Read the full research in the app
A subscription is required to access the full thread.
Open in the app →$LLY INSIGHTS →$LLY INSIGHTS →